Ledger.Open graph →
SEC Form D · filed October 9, 2013

MERSANA THERAPEUTICS INC

Offering
$14.5M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Peter Park · Cambridge, MAExecTimothy B. Lowinger · Cambridge, MAExecSara Nayeem · Cambridge, MADirectorDavid Mott · Cambridge, MADirectorWayne B. Foster · Cambridge, MAExecNicholas G. Bacopoulos · Cambridge, MAExec · DirectorMichael Metzger · Cambridge, MAExecThomas Beck · Cambridge, MADirectorEos Mortar Rock Capital GP, LLC · New York, NYDirectorJim D. Denny · Lexington, KYExec · DirectorRichard A. Farrell · Houston, TXExecZahroof Mohamed · Houston, TXExecMike Lasalle · Los Angeles, CADirectorWilliam Wynperle · Los Angeles, CADirectorMichael B. Pucker · San Francisco, CAExecElm Ridge Capital Management, LLC · Irvington, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗